http://www.bmj.com/cgi/content/full/322/7285/517

 

BMJIntended for health professionals - click here

Home

Help

Search/Archive

Feedback

Table of Contents


PDF of this article

extra: Criteria and tables

Send a response to this article

Electronic responses to this article

Related letters in BMJ

See related This week in BMJ item

Related editorials in BMJ

Other related articles in BMJ

PubMed citation

Related articles in PubMed

Download to Citation Manager

See Correction for this article

This article has been cited by other articles

Search Medline for articles by:
Vincent, C. || Woloshynowych, M.

Alert me when:
New articles cite this article

Collections under which this article appears:
Patient - other
Other Women's health - other
Quality improvement (including CQI and TQM)
General Surgery

BMJ 2001;322:517-519 ( 3 March )

Papers

Adverse events in British hospitals: preliminary retrospective record review

Editorial by Alberti Letters p 548Reviews pp 562, 563

Charles Vincent, professor of psychologyGraham Neale, consultant physicianMaria Woloshynowych, research fellow

Clinical Risk Unit, Department of Psychology, University College London, London WC1E 6BT

Correspondence to: C Vincent c.vincent@ucl.ac.uk


 

  Abstract

Top
Abstract
Introduction
Methods
Results
Discussion
References

Objectives: To examine the feasibility of detecting adverse events through record review in British hospitals and to make preliminary estimates of the incidence and costs of adverse events.
Design: Retrospective review of 1014 medical and nursing records.
Setting: Two acute hospitals in Greater London area.
Main outcome measure: Number of adverse events.
Results: 110 (10.8%) patients experienced an adverse event, with an overall rate of adverse events of 11.7% when multiple adverse events were included. About half of these events were judged preventable with ordinary standards of care. A third of adverse events led to moderate or greater disability or death.
Conclusions: These results suggest that adverse events are a serious source of harm to patients and a large drain on NHS resources. Some are major events; others are frequent, minor events that go unnoticed in routine clinical care but together have massive economic consequences.


 

  Introduction

Top
Abstract
Introduction
Methods
Results
Discussion
References

Retrospective studies of hospital case records in the United States and Australia have shown a substantial rate of adverse events, defined as unintended injuries caused by medical management rather than the disease process. The Harvard medical practice study found that 3.7% of hospital admissions led to adverse events. 1 2 In 70% of these patients the adverse event led to slight or short lived disabilities, but in 7% the disabilities were permanent and in 14% they contributed to death. Similar rates were found in a study from Colorado and Utah. 3 4 The quality in Australian healthcare study identified adverse events in 16.6% of admissions, half of which were considered preventable.5 This study included a wider range of adverse events of minor or moderate severity. Other methodological differences also exaggerate the difference between the United States and Australian figures. 4 6 The Australian study estimated that adverse events accounted for 8% of hospital bed days and cost the Australian healthcare system $4.7bn a year. Adverse events also result in huge personal cost to the affected individuals, both patients and staff.7

The epidemiology of adverse events has not been studied in Britain. We report preliminary findings from a pilot study that examined the feasibility of applying United States and Australian methods and the potential value of a parallel study in the United Kingdom.


 

  Methods

Top
Abstract
Introduction
Methods
Results
Discussion
References

Design and procedure
The study was carried out at two acute hospitals in the London area. We reviewed 500 randomly drawn records from site 1 between July and September 1999 and 514 records from site 2 between December 1999 and February 2000. In both sites the index admissions studied occurred in two months in 1998, about a year before the review periods. We reviewed 273 (26.9%) records from general medicine (including geriatrics), 290 (28.6%) from general surgery, 277 (27.3%) from orthopaedic surgery, and 174 (17.2%) from obstetrics. Admissions to the four specialties studied in 1998-9 were 19 397 in site 1 and 18 335 in site 2. The proportions of admissions studied were 2.6% and 2.8% respectively.

Review process
The review team consisted of an experienced nurse who worked as project manager with four part time research nurses. A consultant physician acted as lead medical assessor, working with five part time surgical and obstetric colleagues, each of whom had been qualified for a minimum of 10 years. Each reviewer screened sets of notes under supervision until they were judged to be fully conversant with the review process.

The nurse reviewers used 18 predefined screening criteria to assess the case records. Records that screened positive (n = 405) were then reviewed by clinicians, who identified any adverse events and completed a detailed questionnaire. The clinicians assessed the impact of each adverse event on the patient in terms of disability and additional bed days, likely cause, place and date of occurrence, type of adverse event (for example, whether related to a particular procedure or treatment), and preventability and recorded detailed clinical information. Records were reviewed once only, although difficult issues were resolved after duplicate review and discussion between two or more assessors. Criteria for adverse events are given on the BMJ 's website. A full description of the methods has been published. 2 5 Copies of the British review forms are available from the authors.


 

  Results

Top
Abstract
Introduction
Methods
Results
Discussion
References

In all, 110 (10.8%) of 1014 patients experienced an adverse event (table 1). However, some patients experienced multiple events, and the overall number of events was 119 (11.7%). There was no significant difference in sex between patients who did and did not experience an adverse event. However, patients with adverse events were older than those who did not experience an adverse event (P<0.001; see tables A and B on BMJ 's website)


                              
View this table:
[in this window]
[in a new window]
 

Table 1. Number of adverse events by specialty

Seventy three (66%) patients who suffered an adverse event had minimal impairment or recovered within one month; 37 (34%) patients developed an injury or complication that resulted in moderate impairment (21 patients; 19%) or permanent impairment (seven patients; 6%) or contributed to death (nine patients; 8%). Overall, 53 (48%) adverse events were judged preventable. The box shows an example of a patient who experienced serious adverse events.


Example of adverse event

A 53 year old man with a history of stroke, multiple resistant Staphylococcus aureus infection, leg ulcers, and heart failure was admitted for treatment of venous ulceration and cellulitis of both legs. He sustained two adverse events:

1. Failure to manage the leg ulcers aggressively led to the development of osteomyelitis. He subsequently had below knee amputation of both legs.

2. Incorrect management of his urinary catheter resulted in necrosis of the tip of the penis. He had suprapubic catheterisation and developed an infection.

The patient's hospital stay was extended by 26 days.

The 119 adverse events resulted in a total of 999 extra bed days, of which 460 (46%) were judged preventable and therefore could have been saved. Each adverse event led to an average of 8.5 additional days in hospital (range 0-70 days) with additional direct costs of £290 268 to the trusts concerned (table 2).


                              
View this table:
[in this window]
[in a new window]
 

Table 2. Estimated cost of adverse events (1999 values)




 

  Discussion

Top
Abstract
Introduction
Methods
Results
Discussion
References

Our pilot study has established the feasibility of conducting a major record review of adverse events in the United Kingdom. We found that 10.8% of patients admitted to hospital experience an adverse event, with an overall 11.7% rate of adverse events when multiple adverse events are included. About half of these events were judged preventable. A third of adverse events led to moderate or greater disability or death. Some adverse events are serious and are traumatic for both staff and patients. Others are frequent, minor events that go unnoticed in routine clinical care and yet together have massive economic consequences.

This study is primarily a pilot and has certain limitations. The study was small and based on only two hospitals. In addition, the case mix does not accurately reflect hospital practice. The specialties included in the review could have higher rates of adverse events than other specialties. Nevertheless, the specialties we chose constitute a large proportion of inpatient care.

Although we cannot extrapolate with any precision, our findings strongly suggest that adverse events are a serious problem in the NHS, as they are in the United States and Australia. We estimate that around 5% of the 8.5 million patients admitted to hospitals in England and Wales each year experience preventable adverse events, leading to an additional three million bed days. The total cost to the NHS of these adverse events in extra bed days alone would be around £1bn a year.


What is already known on this topic

Substantial numbers of patients in hospital in the United States and Australia have been found to suffer adverse events

No data are available for the United Kingdom

What this study adds

In this pilot study about 10% of patients admitted to acute hospitals experienced an adverse event

A third of these events led to moderate or greater impairment

About half of the adverse events were preventable with current standards of care

Preventable adverse events could cost the NHS around £1bn a year in terms of additional bed days

In the United States and Australia retrospective case record analysis has provided the foundation and driving force for initiatives to reduce harm to patients and to make more efficient use of expensive hospital resources. Our findings indicate that a full national study would be justified in the United Kingdom, as indicated in the chief medical officer's recent report.8 We believe that the investigation should cover at least 20 general hospitals (of varying size and type) and include 500 representative case records from each hospital. This would yield around 1000 adverse events for detailed analysis. Such a study would provide reliable information on the numbers, types, and costs of adverse events occurring in NHS hospitals. This would allow the principal causes to be explored and specific risk reduction strategies to be identified and costed. The total cost of such a study would probably be equivalent to the money lost through preventable adverse events in less than eight hours in the NHS.

 

  Acknowledgments

We thank our international colleagues Bob Gibberd, John Hamilton, Bernie Harrison, Eric Thomas, and Ross Wilson for their time and support, and Alastair Gray for advice on economic aspects of the study. We also thank the clinical reviewers: Justice U-Lois, Sebastian Borges, Aubyn Marath, Deirdre Murphy, and Robert Downes; the nurse/midwife screeners: Jayne Moore, Jane Weaver, Sinéad Trainor, Marcia Persaud, and Katie Major; and the staff at the two trusts.

Contributors: CV designed and wrote the original research proposal. GN was lead clinician for the review. MW managed the project and was responsible for data analysis. All authors contributed equally to the final report. CV and GN are guarantors.

 

  Footnotes

Funding: King's Fund, Nuffield Trust, London Region NHS Research and Development Programme, and the Dunhill Medical Trust. The views and opinions expressed in this article do not necessarily reflect those of these bodies.

Competing interests: None declared.

The criteria for adverse events and tables of results is available on the BMJ's website


 

  References

Top
Abstract
Introduction
Methods
Results
Discussion
References


1.

Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, et al. Incidence of adverse events and negligence in hospitalised patients. N Engl J Med 1991; 324: 370-376[Abstract].

2.

Leape LL, Brennan TA, Laird NM, Lawthers AG, Localio AR, Barnes BA, et al. Incidence of adverse events and negligence in hospitalised patients: results of the Harvard medical practice study II. N Engl J Med 1991; 324: 377-384[Abstract].

3.

Gawande AA, Thomas EJ, Zinner MJ, Brennan TA. The incidence and nature of surgical adverse events in Colorado and Utah in 1992. Surgery 1999; 126: 66-75[Medline].

4.

Thomas EJ, Brennan TA. Errors and adverse events in medicine. In Vincent CA, ed. Clinical risk management: enhancing patient safety. 2nd ed. London: BMJ Publications (in press).

5.

Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The quality in Australian health care study. Med J Aust 1995; 163: 458-471[Medline].

6.

Weingart SN, Wilson RMcL, Gibberd RW, Harrison B. Epidemiology of medical error. BMJ 2000; 320: 774-777[Full Text].

7.

Vincent CA. Risk, safety and the dark side of quality. BMJ 1997; 314: 1775-1776[Full Text].

8.

Department of Health. An organisation with a memory: report of an expert group on learning from adverse events in the NHS. London: DoH, 2000.

(Accepted 27 November 2000)


© BMJ 2001

PDF of this article

extra: Criteria and tables

Send a response to this article

Electronic responses to this article

Related letters in BMJ

See related This week in BMJ item

Related editorials in BMJ

Other related articles in BMJ

PubMed citation

Related articles in PubMed

Download to Citation Manager

See Correction for this article

Search Medline for articles by:
Vincent, C. || Woloshynowych, M.

Alert me when:
New articles cite this article

Collections under which this article appears:
Patient - other
Other Women's health - other
Quality improvement (including CQI and TQM)
General Surgery

This article has been cited by other articles:

Rapid Response responses to this article:

Read all Rapid Response responses

Wow! - Stunning figures

Ron Law

bmj.com, 2 Mar 2001 [Response]

The value of data about adverse events

Ricardo Pardo, General Surgeon , Ciudad Real. Spain

bmj.com, 2 Mar 2001 [Response]

Adverse events in British hospitals

K Sankar, Consultant in Genitourinary Medicince , Newcastle General Hospital

bmj.com, 3 Mar 2001 [Response]

Were adverse drug reactions included?

John Wilson, Retired paediatric neurologist , Great ormond Street

bmj.com, 6 Mar 2001 [Response]

Right in retrospect?

R E Ferner, J K Aronson

bmj.com, 7 Mar 2001 [Response]

Will the response to adverse events highlight double Standards?

Dr Janet Richardson, Chairman of the Research Council for Complementary Medicine. , Oxford Brookes University

bmj.com, 8 Mar 2001 [Response]

"The eye of the beholder" - a threshold effect

B T Collopy and I G McDonald, CQM Consultants and Centre for the Study of Clinical Practice , Melbourne, Australia

bmj.com, 8 Mar 2001 [Response]

Explaining the Evidence on Adverse Events

Stephen Heasell, Head of Economics Division , Nottingham Trent University

bmj.com, 9 Mar 2001 [Response]

Sometimes "adverse events" may be inevitable

David Griffith, Paul Diggory & Anand Mehta, Consultant Physicians, Care of Older People , Mayday Healthcare NHS Trust

bmj.com, 9 Mar 2001 [Response]

In-hospital adverse events: Preventive strategies, not epidemiological studies, are needed

Tuan V. Nguyen, Senior Fellow , University of New South Wales

bmj.com, 11 Mar 2001 [Response]

Radiological errors reporting does not identify errors leading to complaints and litigation.

Sam Chakraverty, John Wright, Consultant Radiologist, Associate Medical Director , Ninewells Hospital and Medical School, Dundee, Bradford Hospitals NHS Trust, Bradford

bmj.com, 14 Mar 2001 [Response]

Adverse events in British hospitals

Rosalind Plowman, Jenny Roberts, Nick Graves, Barry Cookson, Lynda Taylor, Mark Griffin

bmj.com, 26 Mar 2001 [Response]

Tip of the Iceberg, Need expanded definition of adverse events.

Stephen Bezruchka, Department of Health Services, School of Public Health and Community Medicine , University of Washington, Seattle, USA

bmj.com, 1 Apr 2001 [Response]

Quick Risk Comparison

Barry Whittingham, Risk Consultant , Home

bmj.com, 6 Apr 2001 [Response]

Re: Quick Risk Comparison

Joseph Watine , Hôpital de Rodez, France

bmj.com, 9 Apr 2001 [Response]

Related letters in BMJ:

Not again!

Philip J Bickford Smith, J R C Seale, Saad M B Rassam, Tim Wilson, Anmol Malhotra, Mathew Matson, Otto Chan, and Roger M Goss
BMJ 2001 322: 548. [Letter]

Adverse events in British hospitals

Tuan V Nguyen, Ken M Hillman, Michael D Buist, S Chakraverty, J Wright, Rosalind Plowman, Jennifer A Roberts, Nicholas Graves, Mark A S Griffin, Barry Cookson, Lynda Taylor, Brian T Collopy, I G McDonald, David Griffith, Paul Diggory, Anand Mehta, Charles Vincent, Graham Neale, Maria Woloshynowych, R E Ferner, J K Aronson, and Stephen Bezruchka
BMJ 2001 322: 1425. [Letter]

Related editorials in BMJ:

Medical errors: a common problem.

K G M M Alberti
BMJ 2001 322: 501-502. [Full text]  

Other related articles in BMJ:

EDITOR'S CHOICE
Medical error: creeping from words to action.

BMJ 2001 322: 0. [Full text]  

EDITOR'S CHOICE [GP]
Medical error: creeping from words to action.

BMJ 2001 322: 0. [Full text]  

PRESS
Press: Blunders will never cease How the media report medical errors A risky business.

Trevor Jackson and Alison Harper
BMJ 2001 322: 562. [Full text]  

WEBSITE OF THE WEEK
Website of the week: Empowering consumers.

Tessa Richards
BMJ 2001 322: 562. [Full text]  

PERSONAL VIEWS
How the Atlantic barons learnt teamwork.

David Johnson
BMJ 2001 322: 563. [Full text]  



Home

Help

Search/Archive

Feedback

Table of Contents

BMJFor Health Professionals

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.